Xeris Biopharma Holdings Inc. buy SVB Leerink LLC
Start price
10.03.25
/
50%
€4.21
Target price
10.03.26
€5.52
Performance (%)
17.02%
End price
11.03.26
€4.92
Summary
This prediction ended on 11.03.26 with a price of €4.92. The prediction had a final performance of 17.02%. SVB_Leerink_LLC has a follow-up prediction for Xeris Biopharma Holdings Inc. where he still thinks Xeris Biopharma Holdings Inc. is a Buy. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | 7.420% | 7.420% | 11.933% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target raised by analysts at Leerink Partners from $5.00 to $6.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten
Current prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€6.61
22.08.25
22.08.25
€7.75
22.08.26
22.08.26
11.26%
17.08.26
17.08.26
